Iannone Robert 4
4 · Jazz Pharmaceuticals plc · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
Jazz Pharmaceuticals EVP Robert Iannone Withholds 6,209 Shares for Taxes
What Happened
- Robert Iannone, EVP, Global Head of R&D & Chief Medical Officer at Jazz Pharmaceuticals (JAZZ), had 6,209 shares withheld to satisfy tax obligations tied to the vesting of previously granted restricted stock units. The shares were valued at $188.69 each, totaling approximately $1,171,576. This disposition (code F) reflects tax withholding, not an open-market sale.
Key Details
- Transaction date: 2026-03-05; Filing date: 2026-03-09.
- Shares involved: 6,209 shares withheld at $188.69 per share; total value ≈ $1,171,576.
- Transaction code: F — shares withheld to cover tax obligations from RSU vesting (footnote confirms withholding).
- Shares owned after transaction: not specified in the provided filing excerpt.
- No 10b5-1 plan or late-filing flag noted in the supplied information.
Context
- Tax-withholding dispositions are routine administrative actions when restricted stock units vest; they are not equivalent to a deliberate open-market sale and generally shouldn’t be read as a directional insider trade signal.
Insider Transaction Report
Form 4
Iannone Robert
EVP, Global Head of R&D & CMO
Transactions
- Tax Payment
Ordinary Shares
[F1]2026-03-05$188.69/sh−6,209$1,171,576→ 88,871 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
Signature
By: /s/Paz Dizon, as attorney in fact For: Robert Iannone|2026-03-09